Navigation Links
New Management Changes Poise USANA for Further Growth
Date:12/15/2011

SALT LAKE CITY, Dec. 15, 2011 /PRNewswire/ -- USANA Health Sciences, Inc. (NYSE: USNA), a global nutritional supplements company, today announced that it has hired Doug Braun as its new vice president of marketing. The company has also appointed Dan Macuga, USANA's former vice president of marketing, public relations and social media, to chief communications officer.

(Logo: http://photos.prnewswire.com/prnh/20110110/LA27593LOGO)

Doug Braun brings to USANA more than 20 years of direct selling experience. Braun was most recently the president of Nikken International, Inc., a direct seller of wellness home technologies, where he provided strategic guidance to thousands of Independent Consultants and was responsible for business development, global sales and marketing.

Prior to Nikken, he worked at Herbalife as the Senior Vice President of Marketing. There, he successfully set and executed worldwide strategies for distributor communications, relationship marketing, and promotional collateral. Additionally, Braun assisted in launching numerous innovative products and new lines of business on four continents and has significant experience working with the Direct Sales Association.

"We are looking forward to having Doug on board and believe his contributions to USANA will be extremely valuable as we poise ourselves for growth in 2012," said Kevin Guest, USANA's president of North America. "His knowledge and experience are well-aligned with the objectives we want to accomplish as we continue to build existing markets and open new markets internationally. We are on track to launch in Thailand, Belgium, and France, are in a great position to expand into additional markets, and have been taking advantage of new opportunities that continue to present themselves to our BabyCare subsidiary in China."

Braun, who starts his new position at USANA's corporate office effective immediately, will fill Macuga's previous position.

Prior to his new role as Chief Communications Officer, Macuga spent 15 successful years with the Chrysler Corporation before coming to USANA in 2007.  Since then, he has built an award-winning PR and social media department from the ground up, expanded USANA's global marketing reach and helped the company achieve record growth in sales.

For more information about USANA's product and company, visit www.usana.com.

About USANA: USANA Health Sciences develops and manufactures high-quality nutritionals, personal care, energy and weight management products that are sold directly to Preferred Customers and Associates throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, China, South Korea, Singapore, Malaysia, the Philippines, Mexico, the Netherlands and the United Kingdom. Learn more at our website (www.USANA.com), read our blog (www.whatsupUSANA.com), like us on Facebook (www.facebook.com/usanahealthsciences), or follow us on Twitter (@usanainc)

Media Contact: Ashley Collins
Executive Director of Marketing, PR, and Social Media
USANA Health Sciences, Inc.
(801) 954-7280
ashley.collins (at) us.usana.com  

 


'/>"/>
SOURCE USANA Health Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
4. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. Cellectar Expands Clinical Management Team
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
9. Lilly Receives NCQA Design Certification for Depression Care Management Program
10. Micromet Announces Changes in Management Team
11. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):